Liminatus Pharma LIMN Ratios (2024-2026)

NASDAQ LIMN
$3.84 -0.07 (-1.79%)
As of: Sep 30, 2026 · 9:49 AM EDT
Reported Financials

Liminatus Pharma Quarterly Ratios

Periods 9 quarters
Latest Jun 2026

Liminatus Pharma ratios data for the quarter ended Jun 2026. These financial ratios cover 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 1.63M0.93M1.65M3.10M
Equity AverageEquity Avg. -18.81M-19.23M-19.50M-14.24M-5.23M-5.73M-4.97M0.08M
Invested CapitalInvested Cap. -15.71M-16.31M0.63M-19.46M-7.36M-0.20M-8.37M1.31M1.74M
Leverage & Solvency
Interest Coverage RatioInterest Cover -11.77-5.86-1.57-2.29-17.95-36.80-46.41-59.07-73.17
Debt Ratio 3.690.761.072.810.520.42
Times Interest Earned -11.77-5.86-1.57-2.29-17.95-36.80-46.41-59.07-73.17
Valuation
Price to BookP/B 20.48
Enterprise Value 300.43M44.47M16.17M4.28M3.14M
Market Capitalization 301.77M45.20M16.51M6.19M6.16M
Return Ratios
Return on Capital Employed [ROCE]ROCE -7,188.34%
Return on Assets [ROA]ROA -149.71%-334.96%-236.09%-133.70%
Return on Equity [ROE]ROE -4,929.02%

Liminatus Pharma Ratios API

Pull Liminatus Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LIMN&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY